Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)
|
January 10, 2008
Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy
John R Pollard
The Lancet. Neurology
|
November 18, 2006
Antiepileptic drugs in development
John R Pollard, Jacqueline French
Current Treatment Options in Neurology
|
June 16, 2009
Antiepileptic drugs and other medications: what interactions may arise?
Ram Mani, John R Pollard
Current Neurology and Neuroscience Reports
|
April 22, 2011
Rescue therapies for seizures
Valeriya S Poukas, John R Pollard, Christopher Todd Anderson
Cancers
|
August 22, 2018
The Impact of p53 Dysfunction in ATR Inhibitor Cytotoxicity and Chemo- and Radiosensitisation
Fiona K Middleton, John R Pollard, Nicola J Curtin
In Vivo (Athens, Greece)
|
November 4, 2020
Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy
Bette S Pollard, Jorge C BLANCOl, John R Pollard
European Journal of Medicinal Chemistry Reports
|
August 25, 2022
Stereospecific antiseizure activity in mouse and rat epilepsy models by a pyridinium inhibitor of TNFα/NFκB signaling
Bette S Pollard, Zhiwei Wen, Kenneth A Jacobson, et al.
Clinical Nuclear Medicine
|
October 25, 2013
Natalizumab-induced progressive multifocal leukoencephalopathy
Ashesh A Thaker, Sarah E Schmitt, John R Pollard, et al.
Current Neurology and Neuroscience Reports
|
May 3, 2013
The diagnosis and treatment of attention deficit hyperactivity disorder in patients with epilepsy
Mesha-Gay Brown, Danielle A Becker, John R Pollard, et al.
Epilepsy Research and Treatment
|
October 26, 2013
Epilepsy surgery: factors that affect patient decision-making in choosing or deferring a procedure
Christopher Todd Anderson, Eva Noble, Ram Mani, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Current Opinion in Investigational Drugs (London, England : 2000)
|
January 10, 2008
Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy
John R Pollard
The Lancet. Neurology
|
November 18, 2006
Antiepileptic drugs in development
John R Pollard, Jacqueline French
Current Treatment Options in Neurology
|
June 16, 2009
Antiepileptic drugs and other medications: what interactions may arise?
Ram Mani, John R Pollard
Current Neurology and Neuroscience Reports
|
April 22, 2011
Rescue therapies for seizures
Valeriya S Poukas, John R Pollard, Christopher Todd Anderson
Cancers
|
August 22, 2018
The Impact of p53 Dysfunction in ATR Inhibitor Cytotoxicity and Chemo- and Radiosensitisation
Fiona K Middleton, John R Pollard, Nicola J Curtin
In Vivo (Athens, Greece)
|
November 4, 2020
Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy
Bette S Pollard, Jorge C BLANCOl, John R Pollard
European Journal of Medicinal Chemistry Reports
|
August 25, 2022
Stereospecific antiseizure activity in mouse and rat epilepsy models by a pyridinium inhibitor of TNFα/NFκB signaling
Bette S Pollard, Zhiwei Wen, Kenneth A Jacobson, et al.
Clinical Nuclear Medicine
|
October 25, 2013
Natalizumab-induced progressive multifocal leukoencephalopathy
Ashesh A Thaker, Sarah E Schmitt, John R Pollard, et al.
Current Neurology and Neuroscience Reports
|
May 3, 2013
The diagnosis and treatment of attention deficit hyperactivity disorder in patients with epilepsy
Mesha-Gay Brown, Danielle A Becker, John R Pollard, et al.
Epilepsy Research and Treatment
|
October 26, 2013
Epilepsy surgery: factors that affect patient decision-making in choosing or deferring a procedure
Christopher Todd Anderson, Eva Noble, Ram Mani, et al.
Page
of 4